Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Revenue (2020 - 2022)

RAPT Therapeutics (RAPT) has disclosed Revenue for 3 consecutive years, with $886000.0 as the latest value for Q2 2022.

  • Quarterly Revenue rose 1.96% to $886000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $886000.0 through Mar 2023, down 72.59% year-over-year, with the annual reading at $1.5 million for FY2022, 59.95% down from the prior year.
  • Revenue hit $886000.0 in Q2 2022 for RAPT Therapeutics, up from $641000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.5 million in Q3 2020 to a low of $641000.0 in Q1 2022.
  • Historically, Revenue has averaged $1.0 million across 3 years, with a median of $950500.0 in 2020.
  • Biggest five-year swings in Revenue: skyrocketed 30.7% in 2021 and later crashed 47.55% in 2022.
  • Year by year, Revenue stood at $1.3 million in 2020, then crashed by 41.94% to $756000.0 in 2021, then increased by 17.2% to $886000.0 in 2022.
  • Business Quant data shows Revenue for RAPT at $886000.0 in Q2 2022, $641000.0 in Q1 2022, and $756000.0 in Q4 2021.